140 related articles for article (PubMed ID: 14571779)
21. A clinical-pathological analysis of drug-induced hepatic injury after liver transplantation.
Zhenglu W; Hui L; Shuying Zh; Wenjuan C; Zhongyang Sh
Transplant Proc; 2007 Dec; 39(10):3287-91. PubMed ID: 18089373
[TBL] [Abstract][Full Text] [Related]
22. [Clinical features and prognostic factors of fulminant hepatic failure in Koreans].
Shin SJ; Ahn SH; Kim HM; Kim JK; Kim BC; Lee JH; Paik YH; Lee KS; Han KH; Chon CY; Moon YM
Korean J Hepatol; 2004 Dec; 10(4):298-307. PubMed ID: 15613805
[TBL] [Abstract][Full Text] [Related]
23. [A single factor analysis of the prognosis of 301 hepatitis failure cases and a study of a scoring system on their prognostic assessment].
Lai N; Guo SH; Zhang DZ; Shi L; Zhong XN; Yuan CL
Zhonghua Gan Zang Bing Za Zhi; 2005 Aug; 13(8):586-9. PubMed ID: 16092981
[TBL] [Abstract][Full Text] [Related]
24. [Clinical features of liver failure in children].
Zhu SS; Zhang HF; Chen JM; Yang XJ; Xu ZQ; Chen DW; Dong Y; Xu CJ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):366-9. PubMed ID: 15650792
[TBL] [Abstract][Full Text] [Related]
25. Biochemical prognostic markers of outcome in non-paracetamol-induced fulminant hepatic failure.
Dabos KJ; Newsome PN; Parkinson JA; Mohammed HH; Sadler IH; Plevris JN; Hayes PC
Transplantation; 2004 Jan; 77(2):200-5. PubMed ID: 14742981
[TBL] [Abstract][Full Text] [Related]
26. Fetal and neonatal hepatic tumors.
Isaacs H
J Pediatr Surg; 2007 Nov; 42(11):1797-803. PubMed ID: 18022426
[TBL] [Abstract][Full Text] [Related]
27. Predictors of fatal outcome in fulminant hepatic failure.
Sarwar S; Khan AA; Alam A; Butt AK; Ahmad I; Niazi AK; Dilshad A
J Coll Physicians Surg Pak; 2006 Feb; 16(2):112-6. PubMed ID: 16499803
[TBL] [Abstract][Full Text] [Related]
28. Case report: fulminant hepatic failure involving duloxetine hydrochloride.
Hanje AJ; Pell LJ; Votolato NA; Frankel WL; Kirkpatrick RB
Clin Gastroenterol Hepatol; 2006 Jul; 4(7):912-7. PubMed ID: 16797245
[TBL] [Abstract][Full Text] [Related]
29. Factors affecting the mortality of pediatric fulminant hepatic failure in relation to hepatitis B virus infection.
Chan PC; Chen HL; Kong MS; Huang FC; Lee HC; Lin CC; Liu CC; Lee IH; Wu TC; Wu SF; Ni YH; Hsu HY; Chang MH
J Gastroenterol Hepatol; 2005 Aug; 20(8):1223-7. PubMed ID: 16048570
[TBL] [Abstract][Full Text] [Related]
30. Factors associated with fulminant liver failure during an outbreak among injection drug users with acute hepatitis B.
Garfein RS; Bower WA; Loney CM; Hutin YJ; Xia GL; Jawanda J; Groom AV; Nainan OV; Murphy JS; Bell BP
Hepatology; 2004 Oct; 40(4):865-73. PubMed ID: 15382123
[TBL] [Abstract][Full Text] [Related]
31. Early prognostic markers for fatal fulminant hepatic failure cases with viral hepatitis: proton nuclear magnetic resonance spectroscopic studies of serum.
Bala L; Mehrotra M; Mohindra S; Saxena R; Khetrapal CL
Dig Liver Dis; 2013 Feb; 45(2):155-63. PubMed ID: 23122710
[TBL] [Abstract][Full Text] [Related]
32. [Prognostic index of acute hepato-cellular damage].
Doria C; Nicotra G; D'Antona GM; Travali S; Messina A; Marino I; Gruttadauria G
Ann Ital Chir; 2007; 78(3):169-76. PubMed ID: 17722489
[TBL] [Abstract][Full Text] [Related]
33. [The significance of blood coagulation test in fulminant hepatic failure].
Kawamura A; Meguro J; Kukita K; Yonekawa M; Imai K; Kobayashi N; Kawamura K; Kasai M
Hokkaido Igaku Zasshi; 1988 Sep; 63(5):805-10. PubMed ID: 3240924
[TBL] [Abstract][Full Text] [Related]
34. Etiology and prognosis of fulminant hepatitis in adults.
Ichai P; Samuel D
Liver Transpl; 2008 Oct; 14 Suppl 2():S67-79. PubMed ID: 18825677
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant therapeutic plasma exchange in liver failure: assessments of clinical and laboratory parameters.
Bektas M; Idilman R; Soykan I; Soydan E; Arat M; Cinar K; Coban S; Tuzun A; Bozkaya H; Ormeci N; Ozden A
J Clin Gastroenterol; 2008; 42(5):517-21. PubMed ID: 18344887
[TBL] [Abstract][Full Text] [Related]
36. Fulminant hepatic failure.
Heneghan MA; Lara L
Semin Gastrointest Dis; 2003 Apr; 14(2):87-100. PubMed ID: 12889583
[TBL] [Abstract][Full Text] [Related]
37. Increased serum and hepatic tissue levels of interleukin-18 in patients with fulminant hepatic failure.
Shinoda M; Wakabayashi G; Shimazu M; Saito H; Hoshino K; Tanabe M; Morikawa Y; Endo S; Ishii H; Kitajima M
J Gastroenterol Hepatol; 2006 Nov; 21(11):1731-6. PubMed ID: 16984598
[TBL] [Abstract][Full Text] [Related]
38. Outcome from molecular adsorbent recycling system (MARS) liver dialysis following drug-induced liver failure.
Lee KH; Lee MK; Sutedja DS; Lim SG
Liver Int; 2005 Oct; 25(5):973-7. PubMed ID: 16162155
[TBL] [Abstract][Full Text] [Related]
39. Detrimental effects of nitric oxide inhibition on hepatic encephalopathy in rats with thioacetamide-induced fulminant hepatic failure: role of nitric oxide synthase isoforms.
Chu CJ; Chang CC; Wang TF; Lee FY; Chang FY; Chen YC; Chan CC; Huang HC; Wang SS; Lee SD
J Gastroenterol Hepatol; 2006 Jul; 21(7):1194-9. PubMed ID: 16824075
[TBL] [Abstract][Full Text] [Related]
40. Fulminant liver failure due to severe veno-occlusive disease after haematopoietic cell transplantation: a depressing experience.
MacQuillan GC; Mutimer D
QJM; 2004 Sep; 97(9):581-9. PubMed ID: 15317927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
